Early Translational Bioanalysis Support

Anapharm Bioanalytics - Anapharm Europe S.L.U.

Spain

Service ID:

EP391S1
Service description

This service supports innovative biotechnology and pharmaceutical companies during early translational and preclinical development stages requiring flexible and scientifically driven bioanalytical support. The service includes exploratory pharmacokinetic (PK), pharmacodynamic (PD) and biomarker bioanalysis for small molecules and biologics using LC-MS/MS and ligand-binding assay platforms. Support may include feasibility studies, assay optimisation, non-GLP bioanalysis and early-stage analytical strategies adapted to the specific maturity and objectives of each programme. The goal of the service is to help innovators generate high-quality bioanalytical data to support translational decision-making, candidate progression and preparation for subsequent regulated development stages. Activities are tailored to the specific needs of each EIC beneficiary and may include scientific discussions, study design support, analytical planning and customised bioanalytical execution. The service is delivered by specialised scientific and project management teams with extensive experience supporting innovative drug development programmes.

Sector
Biotechnology
Pharmaceuticals
Technology Readiness Level
TRL 4 – Technology validated in lab
TRL 5 – Technology validated in relevant environment
TRL 6 – Technology demonstrated in relevant environment
TRL 7 – System prototype demonstration in operational environment
Financial requirements

Services are offered on a fee-for-service basis. Project scope, timelines and pricing are defined case-by-case depending on the scientific, technical and regulatory requirements of each programme. Costs may vary depending on factors such as study design, analytical complexity, development stage, assay requirements and sample volume. The service is available on a flexible collaboration basis adapted to the needs of innovative and early-stage biotech companies.

Typical pricing ranges:

  • Method Transfer / Qualification for non-regulated environments: approximately €10,000 – €15,000
  • Small Molecule Method Development: approximately €20,000 – €40,000
  • Small Molecule Method Validation: approximately €25,000 – €45,000
  • Sample Analysis: approximately €40 – €60 per sample
Disclaimer related to service

Project timelines, deliverables and study scope are defined on a case-by-case basis depending on analytical complexity, study design, material availability and project requirements. Service availability is subject to laboratory capacity and scheduling alignment with the sponsor team.

i

Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!

i

Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project website.

Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.